Members – Departments

Department Members

Theranostics at UHN is a cross-departmental initiative leveraging the expertise of each department.

The Departments that Form Theranostics at UHN

Scroll through the page to view the departments connected with Theranostics at UHN

rmp logo - colour

Radiation Medicine Program

Our cutting-edge radiation technologies and capacity to treat over 8,000 patients every year makes the Radiation Medicine Program at the Princess Margaret the largest of its kind in Canada and one of the largest in North America. 

With a strong focus on research and education, and a commitment to individualized, patient-centred care, our interprofessional team of radiation oncologists, therapists, physicists and nurses supports the assessment, planning, treatment and follow-up care for common, rare and complex forms of cancer. 

University Medical Imaging Toronto (UMIT)

UMIT is one of the largest medical imaging departments in Canada, with cutting-edge technology. Our doctors and highly trained staff provide quality care, diagnoses and image-guided interventions for patients visiting UHN.

We conduct research in 6 systems-based divisions: neuroradiology, musculoskeletal imaging, vascular interventional radiology, abdominal imaging, cardiothoracic imaging and breast imaging. Our researchers have received $8 million to support clinical trials in translation research.

UniversityMedicalImagingToronto_Logo
Techna logo

Techna Technology Development team

Techna is a research institute at the University Health Network, formed in collaboration with the University of Toronto, that focuses on the accelerated development and exploitation of technology for improved health. Techna is designed to shorten the time interval from technology discovery and development to application for the benefit of patients and the health care system. It stimulates and facilitates clinically driven innovation, technology and process development, and translational research. Although technology development is common across all UHN research, Techna represents a paradigm shift towards demand-driven activities and an organizational alignment to the needs of the hospital and research enterprise.

Medical Oncology & Hematology

With an international reputation for novel approaches to research and to clinical care, the Division of Medical Oncology and Hematology at Princess Margaret is the largest comprehensive program of its kind in Canada.

Our multidisciplinary, inter-professional team of internationally recognized medical and hematological oncologists, general practitioners, nurses, trainees and allied health professionals offers people with common, rare and complex forms of cancer access to a range of revolutionary clinical programs and research, including:

  • Novel Phase I, II and III clinical trials
  • Personalized medicine
  • The latest developments in new cancer therapies, including immunotherapy and targeted therapies
UHN Logo
UHN-Research-Logo

The Princess Margaret Research Institute

The Princess Margaret Research Institute, the research arm of the Princess Margaret Cancer Centre, is one of the top 5 cancer research centres in the world. In a 388,588 square foot cutting-edge research facility equipped with state-of-the-art tools, our internationally recognized scientists bring innovation from ‘bench to bedside and back to bench.’

The Centre focuses on cancer research across various fields and disciplines, including genomics, informatics, molecular biology, signalling, structural biology, health services and biophysics.

Surgical Oncology

Princess Margaret offers the most comprehensive surgical cancer care program in Canada. With a world-renowned team of close to 76 surgical oncologists, we offer a broad range of specialized services and are committed to providing access to leading-edge surgical techniques and technologies that improve patient outcomes.

As a member of the University Health Network and through partnerships with local hospitals, Princess Margaret offers people with cancer access to specialized facilities. Newly introduced clinical programs include a Guided Therapeutics (GTx) Program, radio-guided seed localization for intra-operative localization of non-palpable breast cancers, a specialized program in peritoneal malignancies and a robotic surgery program for prostate, gynecologic, thoracic and gastrointestinal cancer treatment.

Working inter-professionally with other members of the healthcare team, our surgeons work within site groups. This means our surgeons can focus their practice and work with each patient’s team of medical, radiation and other healthcare providers to assess, treat and provide follow-up care for common, rare and complex forms of cancer.

DOCS_logo_20171012-01
Princess Margaret Cancer Centre Logo

Princess Margaret Cancer Centre

The Princess Margaret Cancer Centre has 12 site groups and 26 specialty clinics, and more than 3,000 staff who see over 400,000 patient visits every year. 850,000 square feet of clinical space house 202 inpatient beds, 16 linear accelerators, a state-of-the-art Magnetic Resonance-guided Radiation Therapy (MRgRT) suite, and two Leksell Gamma Knife Perfexion units, making it one of the largest comprehensive cancer treatment facilities in the world and the largest radiation treatment centre in Canada.

Princess Margaret sees over 1,000 patients every day and has the capacity to deliver diagnostic, treatment, and follow-up care to close to 200,000 patients and their families every year. In 2016, we saw 17,751 new patients. Among the services provided this past year, we delivered 6,031 cancer surgeries, as well as 37,754 system therapy visits, 91,517 radiation visits, and 428 stem cell transplants.

Through ongoing research, education and innovation, Princess Margaret continues to be on the frontiers of medical, surgical and radiation oncology, embracing the latest technology and international best-practices and setting standards for patient care.

Want to know about the Resources that we use?

Learn more about our platform for cementing a world-leading theranostics program that ultimately improves the outcomes of patients with cancer.